Afuco™ Anti-C. diff Toxin A ADCC Therapeutic Antibody (Actoxumab), ADCC Enhanced
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant human monoclonal antibody expressed in CHO binding to toxin A [C. difficile]. Actoxumab is a human monoclonal antibody designed for the prevention of recurrence of Clostridium difficileinfection.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-TAB-716 |
| Pricing | Inquiry |
| Host | Human |
| Target | C. diff Toxin A |
| Species Reactivity | C. difficile |
| Type | ADCC enhanced antibody |
| Applications | IP, IF, FuncS, FC, Neut, ELISA |
| Storage | Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles. |